Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk
Retatrutide is an unlicensed investigational peptide in the UK with no MHRA or EMA marketing authorisation as of 2024
53 Low B 12 concentrations in the body may be present in different pathophysiological situations, including pregnancy, old age, smoking, and comorbidities such as hypertension, diabetes mellitus, pancreatic insufficiency, autoimmune gastritis, gastrectomy or gastric bypass, diseases or resection of the ileum, bacterial overgrowth, celiac disease, inflammatory bowel disease, or uremia-related malnutrition
Available from: Sedatives and/or anesthetics may be used If necessary, a relaxation medication may be given through an intravenous (IV) line in the patients arm, but the patient is usually conscious during this procedure